Skip to main content
TELCON RF PHARMACEUTICAL. Inc. logo

TELCON RF PHARMACEUTICAL. Inc. — Investor Relations & Filings

Ticker · 200230 ISIN · KR7200230001 KO Manufacturing
Filings indexed 352 across all filing types
Latest filing 2019-05-14 Capital/Financing Update
Country KR South Korea
Listing KO 200230

About TELCON RF PHARMACEUTICAL. Inc.

http://www.telcon-rf.com

TELCON RF PHARMACEUTICAL. Inc. operates across two primary business segments: radio frequency (RF) components and pharmaceuticals. The RF division specializes in the development, manufacturing, and global sale of components for wireless communication equipment. Its main products include RF coaxial connectors, cable assemblies, coaxial couplers, and distributors. The pharmaceutical and biotechnology division is engaged in the development and sale of medicinal products.

Recent filings

Filing Released Lang Actions
전환가액의조정(제7회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing from a Korean company (Telcon RF Pharmaceutical) regarding the adjustment of the conversion price of convertible bonds (CB). This type of disclosure, which details changes to capital structure instruments like convertible debt, falls under the 'Capital/Financing Update' category as it relates to financing activities and capital structure changes.
2019-05-14 Korean
전환가액의조정(제12회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (CB) due to a decline in market price. This type of disclosure, which details changes to capital structure instruments like convertible debt, falls under the 'Capital/Financing Update' category as it directly relates to the company's financing activities and capital structure adjustments.
2019-05-10 Korean
전환가액의조정(제10회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing from Telcon RF Pharmaceutical regarding the adjustment of the conversion price for its 10th series of convertible bonds. This type of disclosure, which details changes to capital structure instruments (convertible debt) due to market price fluctuations, falls under capital and financing updates. It is not a report publication announcement, but a direct disclosure of a financial event affecting the company's capital structure.
2019-05-08 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status of a major shareholder (Hanil Vacuum) and its special related parties in the issuer (Telcon RF Pharmaceutical). This type of filing is specifically used to notify the market when a shareholder crosses a significant ownership threshold (typically 5%), which corresponds to the 'Major Shareholding Notification' category.
2019-04-05 Korean
사업보고서 (2018.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the fiscal year 2018 (January 1, 2018 to December 31, 2018) for Telcon RF Pharmaceutical. It contains detailed sections including company overview, business content, financial statements (consolidated and separate), audit opinions, and management analysis. This structure corresponds to the standard annual filing required by the Financial Supervisory Service in South Korea, which is equivalent to the 10-K filing in the US market. FY 2018
2019-03-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과) for Telcon RF Pharmaceutical. It details the approval of financial statements, board appointments, and voting outcomes for specific agenda items. This falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it provides the official outcome of shareholder votes.
2019-03-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.